Globus Medical Inc (GMED) stock is up 49.16% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives GMED stock a score of 69 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 93. GMED's rank also includes a long-term technical score of 83. The fundamental score for GMED is 31. In addition to the average rating from Wall Street analysts, GMED stock has a mean target price of $85.73. This means analysts expect the stock to climb 4.42% over the next 12 months.
GMED has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on GMED!
Globus Medical Inc (GMED) stock has fallen -1.91% while the S&P 500 has fallen -0.27% as of 12:33 PM on Tuesday, Sep 7. GMED has fallen -$1.60 from the previous closing price of $83.69 on volume of 162,558 shares. Over the past year the S&P 500 has gained 35.75% while GMED is up 49.16%. GMED earned $1.81 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 45.51.
Click Here to get the full Stock Report for Globus Medical Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
